Back

Pre-existing cardiovascular disease does not augment the post-acute sequalae of SARS-CoV-2.

1 September 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Secondary prevention of cardiovascular disease Secondary Prevention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Joel Smith

Melbourne (Australia)

4 More presentations in this session

Presentation thumbnail
An innovative multi-disciplinary cardiometabolic clinic for patients with atherosclerotic cardiovascular disease leads to improved risk factor optimisation compared to standard care
Doctor H. Evans (Gateshead, GB)
Abstract Slides Video
Presentation thumbnail
Mediterranean lifestyle for secondary prevention of cardiovascular disease: the MEDLIFE pilot study
Doctor J. Diaz-Gutierrez (Huelva, ES)
Abstract Slides Video
Presentation thumbnail
In-hospital influenza and COVID-19 vaccine availability during acute coronary syndrome boosts vaccination rates and improves outcomes versus out-of-season patients advised post-discharge vaccination
Doctor A. Meseguer Hernandez (Cartagena, ES)
Abstract Slides Video
Presentation thumbnail
Early predictors of progression of short paroxysmal atrial fibrillation
Associate Professor T. Danilevich (Vinnytsa, UA)
Abstract Slides Video

Access the full session

Session thumbnail
Secondary prevention of cardiovascular disease

The Event

Event poster

ESC Congress 2025

1 September 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
The incidence of cardiovascular conditions in patients admitted to hospital with and without COVID-19 in the South-East of Scotland
thumbnail
Congress Session
Long-term impact of COVID-19: direct and indirect consequences
thumbnail
Congress Presentation
Substantial morbidity and mortality due to cardiovascular diseases in hospitalized vaccinated and un-vaccinated patients with COVID-19 from 16 countries: the WHF COVID-19 Long-term study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources